Filter posts

Q & A with Eli Lilly’s Eric Siemers

In October 2012, Eli Lilly and Company released results of its Expedition trials, two Phase …

New Challenges in the Fast Changing Landscape of Bioinformatics

The world of DNA sequencing and bioinformatics has evolved at a staggering pace. In 2009, …

Worldwide Orphan Drug Market to Grow to $127 Billion by 2018

The 2013 Orphan Drug Report from Evaluate, which launched today at the 2013 BIO international …

Finding Biotech in the Silicon Prairie

The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the …

Expanding Access to Orphan Drugs

At present many orphan diseases do not have any licensed treatments, and for those conditions …

Opening Up Innovation

Open Innovation has become a major theme in the life sciences over the last couple …

Our Health Care Ecosystem

There are currently 907 drugs and vaccines targeting more than 100 diseases in development by …

Legislative Hopes, Fears

Biotechnology advances are poised now more than ever to help policymakers achieve their goals of …

BioGENEius Challenge: The Very Real Students of BIO

With the 2013 BioGENEius Challenge underway, we’ll soon find out who will be one of the new …

Approving Drugs for Alzheimer’s Disease

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory …